SB 51
The Cost-Sharing Contributions for Prescriptions would prohibit discrimination against entities participating in the federal 340B drug pricing program. It states that pharmacy benefit managers and third parties cannot discriminate against entities that participate in the 340B program by: Reimbursing a covered entity less than it would an entity not covered by the 340B program, Assessing covered entities fees or other assessments different from non-covered entities, preventing or interfering with a patient’s right to use a 340B program drug from a covered entity, Imposing different requirements for covered vs. non-covered entities, including: [...]